A prospective study to assess the efficacy and safety of oral propranolol as first-line treatment for infantile superficial hemangioma |
Yun, Yeong Ju
(Department of Pediatrics, Chungbuk National University College of Medicine)
Gyon, Yun Hee (Department of Pediatrics, Chungbuk National University College of Medicine) Yang, Sohyoung (Department of Pediatrics, Chungbuk National University College of Medicine) Lee, Youn Kyung (Department of Pediatrics, Chungbuk National University College of Medicine) Park, Joohyun (Department of Pediatrics, Chungbuk National University College of Medicine) Park, Meerim (Department of Pediatrics, Chungbuk National University College of Medicine) |
1 | Leaute-Labreze C, Prey S, Ezzedine K. Infantile haemangioma: part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol 2011;25:1254-60. DOI |
2 | Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. DOI |
3 | Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999;341:173-81. DOI |
4 | Tan ST, Velickovic M, Ruger BM, Davis PF. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg 2000;106:529-38. DOI |
5 | Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-22. DOI |
6 | Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006;118:882-7. DOI |
7 | Beck DO, Gosain AK. The presentation and management of hemangiomas. Plast Reconstr Surg 2009;123:181e-91e. DOI |
8 | Greinwald JH Jr, Burke DK, Bonthius DJ, Bauman NM, Smith RJ. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999;125: 21-7. DOI |
9 | Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, Mac Donald D, Folkman J, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132 (3 Pt 1):527-30. DOI |
10 | Fawcett SL, Grant I, Hall PN, Kelsall AW, Nicholson JC. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004;57:168-71. DOI |
11 | Wharton S, Soucid A, Nishikawa H, Sridhar AV. Endangering cutaneous infantile hemangioma treated with vincristine: a case report. Eur J Plast Surg 2009;32:157-61. DOI |
12 | Sondhi V, Patnaik SK. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol. J Pediatr Hematol Oncol 2013;35:493-9. DOI |
13 | Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423-31. DOI |
14 | Love JN, Sikka N. Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med 2004;26:309-14. DOI |
15 | Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009;73:1168-72. DOI |
16 | Fuchsmann C, Quintal MC, Giguere C, Ayari-Khalfallah S, Guibaud L, Powell J, et al. Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg 2011;137: 471-8. DOI |
17 | Chik KK, Luk CK, Chan HB, Tan HY. Use of propranolol in infantile haemangioma among Chinese children. Hong Kong Med J 2010; 16:341-6. |
18 | Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2846; author reply 2846-7. DOI |
19 | Haggstrom AN, Beaumont JL, Lai JS, Adams DM, Drolet BA, Frieden IJ, et al. Measuring the severity of infantile hemangiomas: instrument development and reliability. Arch Dermatol 2012;148: 197-202. DOI |
20 | Chakkittakandiyil A, Phillips R, Frieden IJ, Siegfried E, Lara-Corrales I, Lam J, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol 2012;29:28-31. DOI |
21 | Xiao Q, Li Q, Zhang B, Yu W. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence. Pediatr Surg Int 2013;29:575-81. DOI |
22 | Schiestl C, Neuhaus K, Zoller S, Subotic U, Forster-Kuebler I, Michels R, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 2011;170:493-501. DOI |